Chest physiotherapy is a critical component of respiratory care aimed at improving airway clearance, enhancing lung function, and preventing complications in patients with various pulmonary conditions. This therapeutic approach employs a combination of manual techniques, postural drainage, percussion, vibration, and breathing exercises to mobilize mucus and secretions from the airways, facilitating their removal. Chest physiotherapy is particularly beneficial for individuals with chronic respiratory diseases, such as cystic fibrosis, bronchiectasis, chronic obstructive pulmonary disease, and pneumonia, as well as patients recovering from surgery or prolonged mechanical ventilation. Implementation requires a thorough assessment of the patient’s lung status, airway obstruction patterns, and overall health to tailor interventions effectively. Collaboration between physiotherapists, pulmonologists, and nursing staff ensures safe and coordinated care, optimizing both efficacy and patient comfort. Education and active participation of patients or caregivers in performing techniques at home enhance long-term outcomes, including reduced frequency of infections, improved oxygenation, and increased exercise tolerance. Advances in technology, such as mechanical devices that simulate manual techniques, have expanded the accessibility and consistency of therapy. Evidence indicates that consistent application of chest physiotherapy not only aids in symptom relief but also contributes to better quality of life and reduced hospitalizations. By combining skilled techniques, patient engagement, and individualized care plans, chest physiotherapy supports airway health, promotes respiratory efficiency, and strengthens overall lung function in both acute and chronic respiratory conditions.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation